---
title: Efficacy of Honan Balloon in Intraocular Pressure Reduction Before Phacoemulsification
nct_id: NCT00386438
overall_status: COMPLETED
phase: PHASE4
sponsor: Chulalongkorn University
study_type: INTERVENTIONAL
primary_condition: Cataract
countries: Thailand
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT00386438.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT00386438"
ct_last_update_post_date: 2006-10-11
last_seen_at: "2026-05-12T06:43:53.913Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Efficacy of Honan Balloon in Intraocular Pressure Reduction Before Phacoemulsification

**NCT ID:** [NCT00386438](https://clinicaltrials.gov/study/NCT00386438)

## Key Facts

- **Status:** COMPLETED
- **Phase:** PHASE4
- **Study Type:** INTERVENTIONAL
- **Lead Sponsor:** Chulalongkorn University
- **Conditions:** Cataract
- **Start Date:** 2005-12
- **Completion Date:** 2006-07
- **CT.gov Last Update:** 2006-10-11

## Brief Summary

-Does Honan balloon reduce intraocular pressure preoperatively?

## Detailed Description

-Does Honan balloon improve surgeon's satisfaction and patients' pain score when compared to no honan group?

## Eligibility

- **Minimum age:** 0 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* cataract patient,who plan to undergo phacoemulsification
* no previous ocular surgery

Exclusion Criteria:

* one eye
* high myopia
* Use ASA or anticoagulants
* History of glaucoma or ocular hypertension
* uncooperative patients
```

## Interventions

- **Honan balloon application** (PROCEDURE)

## Primary Outcomes

- **intraocular pressure reduction**

## Secondary Outcomes

- **pain score**

## Locations (1)

- King Chulalongkorn Memorial hospital, Patumwan, Bangkok, Thailand

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.king chulalongkorn memorial hospital|patumwan|bangkok|thailand` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT00386438.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT00386438*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*